col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


77 Results       Page 1

 [1] 
BMJ: RMD Open
  original article Date Title Authors   Max. 6 Authors
1 [GO] 2023―Nov―29 COVID-19 Vaccine in Immunosuppressed Adults with Autoimmune rheumatic Diseases (COVIAAD): safety, immunogenicity and antibody persistence at 12 months following Moderna Spikevax primary series Ines Colmegna, Valeria Valerio, Nathalie Amiable, Mariana Useche, Emmanouil Rampakakis, Louis Flamand, Emmanuelle Rollet-Labelle, Louis Bessette, Mary-Ann Fitzcharles, Elizabeth Hazel, Deirdre McCormack, Laëtitia Michou, Pantelis Panopalis, Marc-André Langlois, Sasha Bernatsky, Paul R Fortin
2 [GO] 2023―Nov―17 COVID-19 infection and efficacy of vaccination in patients with rheumatic diseases during Omicron outbreak in South Korea: a prospective cohort study Yun Kyu Kim, Ju Yeon Kim, Ji In Jung, Jin Kyun Park, Eun Young Lee, Eun-Bong Lee, Jun Won Park
3 [GO] 2023―Aug―31 Impact of different classes of immune-modulating treatments on B cell-related and T cell-related immune response before and after COVID-19 booster vaccination in patients with immune-mediated diseases and primary immunodeficiency: a cohort study Michaela Koehm, Maximilian Klippstein, Stephanie Dauth, Konstantin Hallmann, Niko Kohmer, Harald Burkhardt, Sandra Ciesek, Gerd Geisslinger, Holger F Rabenau, Frank Behrens
4 [GO] 2023―Aug―28 Outcomes of COVID-19 in patients with ANCA-associated vasculitis receiving avacopan Faten Aqeel, Reza Zonozi, Anushya Jeyabalan, Gabriel Sauvage, John L Niles, Duvuru Geetha
5 [GO] 2023―Aug―17 Risk factors for severe COVID-19 among patients with systemic lupus erythematosus: a real-world analysis of a large representative US administrative claims database, 2020-2021 Cassandra Calabrese, Gelareh Atefi, Kristin A Evans, Meghan Moynihan, Liisa Palmer, Sze-Jung Wu
6 [GO] 2023―Jul―21 COVID-19 outcomes in patients with rheumatoid arthritis with biologic or targeted synthetic DMARDs Jih-Jin Tsai, Li-Teh Liu, Chun-Hong Chen, Liang-Jen Chen, Shiow-Ing Wang, James Cheng-Chung Wei
7 [GO] 2023―Jun―16 Inflammatory rheumatic diseases with onset after SARS-CoV-2 infection or COVID-19 vaccination: a report of 267 cases from the COVID-19 and ASD group Francesco Ursini, Piero Ruscitti, Olga Addimanda, Rosario Foti, Vincenzo Raimondo, Giuseppe Murdaca, Virginia Caira, Erika Pigatto, Giovanna Cuomo, Alberto Lo Gullo, Ilaria Cavazzana, Corrado Campochiaro, Caterina Naclerio, Rossella De Angelis, Jacopo Ciaffi, Luana Mancarella, Veronica Brusi, Elena Marchetti, Francesca Motta, Marcella Visentini, Sebastiano Lorusso, Maria De Santis, Giacomo De Luca, Laura Massaro, Domenico Olivo, Roberta Pellegrini, Francesca Francioso, Jessica Luppino, Ilenia Di Cola, Roberta Foti, Giuseppe Varcasia, Francesco Caso, Massimo Reta, Lorenzo Dagna, Carlo Selmi, Annamaria Iagnocco, Roberto Giacomelli, Florenzo Iannone, Clodoveo Ferri
8 [GO] 2023―Apr―17 Characteristics and outcomes of SARS-CoV-2 breakthrough infections among double-vaccinated and triple-vaccinated patients with inflammatory rheumatic diseases Rebecca Hasseli, Jutta G. Richter, Bimba Franziska Hoyer, Hanns-Martin Lorenz, Alexander Pfeil, Anne Constanze Regierer, Tim Schmeiser, Anja Strangfeld, Reinhard E Voll, Andreas Krause, Sabine Reckert, Anett Gräßler, Petra Saar, Andreas Kapelle, Marina Backhaus, Norbert Blank, Joerg Henes, Silke Osiek, Anna Knothe, Guido Hoese, Jan Brandt-Jürgens, Anja Maltzahn, Christof Specker, Ulf Müller-Ladner, Hendrik Schulze-Koops
9 [GO] 2023―Mar―16 Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease: an extension study (RESCUE 2) Ai Phuong Tran, D.F Tassone, N S Ding, Johannes Nossent
10 [GO] 2023―Mar―16 Effects of COVID-19 vaccination on disease activity in patients with rheumatoid arthritis and psoriatic arthritis on targeted therapy in the COVIDSER study José M Álvaro-Gracia, Carlos Sanchez-Piedra, Dante Culqui, Rosa Rosello, Alicia Garcia-Dorta, Cristina Campos, Sara Manrique-Arija, Dolores Ruiz-Montesinos, Inmaculada Ros-Vilamajo, Carlos Rodríguez-Lozano, Mercedes Freire-González, Rafael Caliz, Cristina Bohorquez, Lourdes Mateo Soria, Noemí Busquets, Isabel Castrejon, Fernando Sánchez-Alonso, Enrique González-Dávila, Federico Diaz-Gonzalez
11 [GO] 2023―Mar―08 Risk of COVID-19 among unvaccinated and vaccinated patients with systemic lupus erythematosus: a general population study Xiaofeng Jiang, Jeffrey Sparks, Zachary Wallace, Xinjia Deng, Hui Li, Na Lu, Dongxing Xie, Yilun Wang, Chao Zeng, Guanghua Lei, Jie Wei, Yuqing Zhang
12 [GO] 2023―Feb―14 Thrombotic and immunological phenomena following COVID-19 vaccination: experience from a case series Chathurika Lakmini Dandeniya, Theekshana Kavinda Premathilake
13 [GO] 2022―Dec―06 Mild COVID-19 despite inadequate antibody response after repeated vaccinations in rheumatic disease patients with rituximab-induced B cell depletion: a case series Alexander ten Hagen, Elisa Habermann, Sandra Hermann, Gerd R Burmester, Robert Biesen, Fredrik N. Albach
14 [GO] 2022―Dec―06 Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, Veronika Scholz, Tanja Braun, Lara Maria Jeworowski, Tatjana Schwarz, Pinkus Tober-Lau, Alexander ten Hagen, Elisa Habermann, Florian Kurth, Leif Erik Sander, Victor Max Corman, Gerd-Rüdiger Burmester, Robert Biesen, Fredrik N. Albach, Jens Klotsche
15 [GO] 2022―Dec―02 Outcome of COVID-19 in patients with rheumatic and inflammatory diseases treated with mycophenolic acid: data from the French RMD COVID-19 cohort Marie-Elise Truchetet, Elodie Drumez, Thomas Barnetche, Claire Martin, Mathilde Devaux, Tiphaine Goulenok, Alexandre Maria, Jean Schmidt, Nassim Ait Abdallah, Isabelle Melki, Eric Hachulla, Christophe Richez
16 [GO] 2022―Nov―03 Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy Silje Watterdal Syversen, Ingrid Jyssum, Anne Therese Tveter, Joe Sexton, Ingrid Egeland Christensen, Trung T Tran, Kristin Hammersbøen Bjørlykke, Siri Mjaaland, David J Warren, Tore K Kvien, Adity Chopra, Grete Birkeland Kro, Jorgen Jahnsen, Ludvig A Munthe, Espen A Haavardsholm, Gunnveig Grødeland, John Torgils Vaage, Sella Aarrestad Provan, Kristin Kaasen Jørgensen, Guro Løvik Goll
17 [GO] 2022―Oct―10 Pausing methotrexate prevents impairment of Omicron BA.1 and BA.2 neutralisation after COVID-19 booster vaccination Elisa Habermann, Lutz Gieselmann, Pinkus Tober-Lau, Jens Klotsche, Fredrik Nils Albach, Alexander ten Hagen, Jan Zernicke, Elvin Ahmadov, Amanthi Nadira Arumahandi de Silva, Leonie Maria Frommert, Florian Kurth, Leif Erik Sander, Gerd R Burmester, Florian Klein, Robert Biesen
18 [GO] 2022―Oct―10 Reduced humoral response to a third dose (booster) of SARS-CoV-2 mRNA vaccines by concomitant methotrexate therapy in elderly patients with rheumatoid arthritis David Stahl, Carola tho Pesch, Carolin Brück, Ruth L Esser, Jan Thiele, Veronica Di Cristanziano, David M Kofler
19 [GO] 2022―Sep―15 Impact of the COVID-19 pandemic on work productivity in patients with spondyloarthritis: results from the Dutch SpA-Net registry Casper Webers, Astrid van Tubergen, Harald E Vonkeman, Annelies Boonen
20 [GO] 2022―Sep―14 Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey Michael DiIorio, Kevin Kennedy, Jean W Liew, Michael S Putman, Emily Sirotich, Sebastian E Sattui, Gary Foster, Carly Harrison, Maggie J Larché, Mitchell Levine, Tarin T Moni, Lehana Thabane, Suleman Bhana, Wendy Costello, Rebecca Grainger, Pedro M Machado, Philip C Robinson, Paul Sufka, Zachary S Wallace, Jinoos Yazdany, Monique Gore-Massy, Richard A Howard, More A Kodhek, Nadine Lalonde, Laura-Ann Tomasella, John Wallace, Akpabio Akpabio, Deshiré Alpízar-Rodríguez, Richard P Beesley, Francis Berenbaum, Inita Bulina, Eugenia Yupei Chock, Richard Conway, Alí Duarte-García, Eimear Duff, Tamer A Gheita, Elizabeth R Graef, Evelyn Hsieh, Lina El Kibbi, David FL Liew, Chieh Lo, Michal Nudel, Aman Dev Singh, Jasvinder A Singh, Namrata Singh, Manuel F Ugarte-Gil, Jonathan S Hausmann, Julia F Simard, Jeffrey A Sparks
21 [GO] 2022―Sep―14 Different humoral but similar cellular responses of patients with autoimmune inflammatory rheumatic diseases under disease-modifying antirheumatic drugs after COVID-19 vaccination Ioana Andreica, Arturo Blazquez-Navarro, Jan Sokolar, Moritz Anft, Uta Kiltz, Stephanie Pfaender, Elena Vidal Blanco, Timm Westhoff, Nina Babel, Ulrik Stervbo, Xenofon Baraliakos
22 [GO] 2022―Sep―13 Factors associated with severe COVID-19 in people with idiopathic inflammatory myopathy: results from the COVID-19 Global Rheumatology Alliance physician-reported registry Su-Ann Yeoh, Milena Gianfrancesco, Saskia Lawson-Tovey, Kimme L Hyrich, Anja Strangfeld, Laure Gossec, Loreto Carmona, Elsa F Mateus, Martin Schäfer, Christophe Richez, Eric Hachulla, Marie Holmqvist, Carlo Alberto Scirè, Hanns-Martin Lorenz, Reinhard E Voll, Rebecca Hasseli, Arundathi Jayatilleke, Tiffany Y-T Hsu, Kristin M D’Silva, Victor R Pimentel-Quiroz, Monica Vasquez del Mercado, Samuel Katsuyuki Shinjo, Edgard Torres dos Reis Neto, Laurindo Ferreira da Rocha Junior, Ana Carolina de Oliveira e Silva Montandon, Guillermo J Pons-Estel, Sofía Ornella, Maria Eugenia D'Angelo Exeni, Edson Velozo, Paula Jordan, Emily Sirotich, Jonathan S Hausmann, Jean W Liew, Lindsay Jacobsohn, Monique Gore-Massy, Paul Sufka, Rebecca Grainger, Suleman Bhana, Zachary Wallace, Philip C Robinson, Jinoos Yazdany, Pedro M Machado
23 [GO] 2022―Sep―13 COVID-19-associated arthritis: an emerging new entity? Bayram Farisogullari, Ana S Pinto, Pedro M Machado
24 [GO] 2022―Sep―12 Reactive arthritis after SARS-CoV-2 infection Sophia Dombret, Alla Skapenko, Hendrik Schulze-Koops
25 [GO] 2022―Sep―09 Third dose corrects waning immunity to SARS-CoV-2 mRNA vaccines in immunocompromised patients with immune-mediated inflammatory diseases Michelle W Cheung, Roya M Dayam, Jaclyn C Law, Rogier L Goetgebuer, Gary Y C Chao, Naomi Finkelstein, Joanne M Stempak, Daniel Pereira, David Croitoru, Lily Acheampong, Saima Rizwan, Jenny D Lee, Darshini Ganatra, Ryan Law, Melanie Delgado-Brand, Geneviève Mailhot, Vincent Piguet, Mark S Silverberg, Tania H Watts, Anne-Claude Gingras, Vinod Chandran
26 [GO] 2022―Sep―07 Humoral and cellular SARS-CoV-2 vaccine responses in patients with giant cell arteritis and polymyalgia rheumatica Yannick van Sleen, Kornelis S M van der Geest, Rosanne D Reitsema, Idil Esen, Janneke H Terpstra, Elisabeth Raveling-Eelsing, Marieke van der Heiden, Thomas Lieber, Annemarie M Buisman, Debbie van Baarle, Maria Sandovici, Elisabeth Brouwer
27 [GO] 2022―Aug―01 SARS-CoV-2 vaccine safety in adolescents with inflammatory rheumatic and musculoskeletal diseases and adults with juvenile idiopathic arthritis: data from the EULAR COVAX physician-reported registry Saskia Lawson-Tovey, Pedro M Machado, Anja Strangfeld, Elsa Mateus, Laure Gossec, Loreto Carmona, Bernd Raffeiner, Inita Bulina, Daniel Clemente, Julija Zepa, Ana M. Rodrigues, Xavier Mariette, Kimme L Hyrich
28 [GO] 2022―May―23 Antibody response to the COVID-19 ChAdOx1nCov-19 and BNT162b vaccines after temporary suspension of DMARD therapy in immune-mediated inflammatory disease (RESCUE) Ai Phuong Tran, Daniel Tassone, Johannes Nossent, Nik Sheng Ding
29 [GO] 2022―May―23 COVID-19 infection among patients with autoinflammatory diseases: a study on 117 French patients compared with 1545 from the French RMD COVID-19 cohort: COVIMAI - the French cohort study of SARS-CoV-2 infection in patient with systemic autoinflammatory diseases Rim Bourguiba, Maeva Kyheng, Isabelle Koné-Paut, Diane Rouzaud, Jerome Avouac, Mathilde Devaux, Nassim Ait Abdallah, Bruno Fautrel, Nicole Ferreira-Maldent, Vincent Langlois, Emmanuel Ledoult, Hubert Nielly, Viviane Queyrel, Jérémie Sellam, Nathalie Tieulie, Pascal Chazerain, Philippe Evon, Julien Labreuche, Léa Savey, Veronique Hentgen, Gilles Grateau, Sophie Georgin-lavialle
30 [GO] 2022―May―19 Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses Samuel Bitoun, Jérôme Avouac, Julien Henry, Roba Ghossan, Omar Al Tabaa, Rakiba Belkhir, Gaetane Nocturne, Alice Andrée Mariaggi, Flore Rozenberg, Christelle Vauloup-Fellous, Xavier Mariette, Raphaèle Seror
31 [GO] 2022―May―19 Effects of casirivimab/imdevimab on systemic and mucosal immunity against SARS-CoV-2 in B-cell depleted patients with autoimmune rheumatic diseases refractory to vaccination Filippo Fagni, Katja Schmidt, Daniela Bohr, Larissa Valor-Méndez, Fabian Hartmann, Koray Tascilar, Karin Manger, Bernhard Manger, Arnd Kleyer, David Simon, Georg Schett, Thomas Harrer
32 [GO] 2022―May―10 SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry Jean Liew, Milena Gianfrancesco, Carly Harrison, Zara Izadi, Stephanie Rush, Saskia Lawson-Tovey, Lindsay Jacobsohn, Clairissa Ja, Kimme L Hyrich, Laure Gossec, Anja Strangfeld, Loreto Carmona, Martin Schäfer, Elsa Frãzao-Mateus, Inita Bulina, Frances Stafford, Abdurrahman Tufan, Christine Graver, Gözde Kübra Yardımcı, Julija Zepa, Samar Al Emadi, Claire Cook, Fatemah Abutiban, Dfiza Dey, Genevieve Katigbak, Lauren Kaufman, Emily Kowalski, Marco Ulises Martínez-Martínez, Naomi J Patel, Greta Reyes-Cordero, Evelyn Salido, Ellison Smith, David Snow, Jeffrey Sparks, Leanna Wise, Suleman Bhana, Monique Gore-Massy, Rebecca Grainger, Jonathan Hausmann, Emily Sirotich, Paul Sufka, Zachary Wallace, Pedro M Machado, Philip C Robinson, Jinoos Yazdany
33 [GO] 2022―May―10 Does an adjustment to the dosing and timing of immunomodulatory drugs alter the immunogenicity of the COVID-19 vaccines in patients with autoimmune and inflammatory rheumatic disease (AIIRD)? Andrew J Laster, Gordon K Lam, Heather S Gladue, Ahmad A Kashif, Erin P Siceloff, Virginia D Lackey, Cheryl R Robertson, Ashley L Toci, Leonard H Calabrese
34 [GO] 2022―Apr―12 Immunogenicity and safety of COVID-19 vaccination in patients with primary Sjögren’s syndrome Gwenny M Verstappen, Liseth de Wolff, Suzanne Arends, Hella-Marie Heiermann, Yannick van Sleen, Annie Visser, Janneke H Terpstra, Dimitri A Diavatopoulos, Marieke van der Heiden, Arjan Vissink, Debbie van Baarle, Frans G M Kroese, Hendrika Bootsma
35 [GO] 2022―Apr―05 Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study Laura Boekel, Femke Hooijberg, Erik H Vogelzang, Yaëlle R Besten, Maureen Leeuw, Sadaf Atiqi, Ronald F van Vollenhoven, Carla A Wijbrandts, Martijn Gerritsen, C Krieckaert, Bas Dijkshoorn, Siham Bakhlakh, Juliette J Crooijmans, Alexandre Voskuyl, Irene E van der Horst-Bruinsma, Willem Lems, Taco W Kuijpers, S Marieke van Ham, Luuk Wieske, Filip Eftimov, Laura Y Kummer, PJ Koos van Dam, Eileen W Stalman, Maurice Steenhuis, Sofie Keijzer, Olvi Cristianawati, Jim Keijser, Floris C Loeff, Sander W Tas, Michael T Nurmohamed, Maarten Boers, Theo Rispens, Gertjan Wolbink
36 [GO] 2022―Apr―01 Effectiveness of SARS-CoV-2 vaccination in patients with rheumatoid arthritis (RA) on DMARDs: as determined by antibody and T cell responses Benazir Saleem, Rebecca L Ross, Lesley-Anne Bissell, Aamir Aslam, Kulveer Mankia, Laurence Duquenne, Diane Corsadden, Clive Carter, Pam Hughes, Fatima A Nadat, Panji Mulipa, Mark Lobb, Brendan Clarke, Katie Mbara, Ruth Morton, Sophie Dibb, Rahaymin Chowdhury, Darren Newton, Alexandra Pike, Vishal Kakkar, Sinisia Savic, Francesco DelGaldo, Paul Emery
37 [GO] 2022―Mar―31 Correction: Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases
38 [GO] 2022―Mar―31 Trajectories of humoral and cellular immunity and responses to a third dose of mRNA vaccines against SARS-CoV-2 in patients with a history of anti-CD20 therapy Daniel Sidler, Alexander Born, Simeon Schietzel, Michael P Horn, Daniel Aeberli, Jennifer Amsler, Burkhard Möller, Linet M Njue, Cesare Medri, Anne Angelillo-Scherrer, Luca Borradori, S. Morteza Seyed Jafari, Susanne Radonjic-Hoesli, Andrew Chan, Robert Hoepner, Ulrike Bacher, Laila-Yasmin Mani, Joseena Mariam Iype, Franziska Suter-Riniker, Cornelia Staehelin, Michael Nagler, Cedric Hirzel, Britta Maurer, Matthias B Moor
39 [GO] 2022―Mar―04 Clinical outcomes of breakthrough COVID-19 after booster vaccination in patients with systemic rheumatic diseases George E Fragoulis, Anastasios Karamanakos, Aikaterini Arida, Vasiliki-Kalliopi Bournia, Gerasimos Evangelatos, Antonis Fanouriakis, Kalliopi Fragiadaki, Evrydiki Kravvariti, Katerina Laskari, Stylianos Panopoulos, Nikolaos Papazoglou, Maria Pappa, Maria G G Tektonidou, Petros P Sfikakis
40 [GO] 2022―Feb―07 Production of anti-PF4 antibodies in antiphospholipid antibody-positive patients is not affected by COVID-19 vaccination Paola Adele Lonati, Caterina Bodio, Mariangela Scavone, Giuliana Martini, Elisa Pesce, Alessandra Bandera, Andrea Lombardi, Maria Gerosa, Franco Franceschini, Angela Tincani, Gianmarco Podda, Sergio Abrignani, Renata Grifantini, Marco Cattaneo, Maria Orietta Borghi, Pier Luigi Meroni
41 [GO] 2022―Feb―03 Humoral and cellular immune responses on SARS-CoV-2 vaccines in patients with anti-CD20 therapies: a systematic review and meta-analysis of 1342 patients Simeon Schietzel, Manuel Anderegg, Andreas Limacher, Alexander Born, Michael P Horn, Britta Maurer, Cedric Hirzel, Daniel Sidler, Matthias B Moor
42 [GO] 2022―Feb―02 Breakthrough infection after three doses of COVID-19 mRNA vaccine in systemic autoimmune rheumatic diseases: two cases in patients on TNF inhibitor monotherapy Kathleen MM Vanni, Naomi J Patel, Michael DiIorio, Emily Kowalski, Grace Qian, Claire E Cook, Susan Y Ritter, Zachary S Wallace, Jeffrey A Sparks
43 [GO] 2022―Jan―18 Correction: Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision
44 [GO] 2022―Jan―05 Immune responses to mRNA vaccines against SARS-CoV-2 in patients with immune-mediated inflammatory rheumatic diseases Cristiana Sieiro Santos, Sara Calleja Antolin, Clara Moriano Morales, Juan Garcia Herrero, Elvira Diez Alvarez, Fernando Ramos Ortega, Jose G Ruiz de Morales
45 [GO] 2022―Jan―05 Immunogenicity of BNT162b2 mRNA SARS-CoV-2 vaccine in patients with psoriatic arthritis on TNF inhibitors Vincenzo Venerito, Pasquale Stefanizzi, Marco Fornaro, Fabio Cacciapaglia, Silvio Tafuri, Simone Perniola, Florenzo Iannone, Giuseppe Lopalco
46 [GO] 2021―Dec―09 Role of targeted therapies in rheumatic patients on COVID-19 outcomes: results from the COVIDSER study Jose María Álvaro Gracia, Carlos Sanchez-Piedra, Javier Manero, María Ester Ruiz-Lucea, Laura López-Vives, Cristina Bohorquez, Julia Martinez-Barrio, Gema Bonilla, Paloma Vela, María Jesús García-Villanueva, María Teresa Navío-Marco, Marina Pavía, María Galindo, Celia Erausquin, Miguel A Gonzalez-Gay, Inigo Rua-Figueroa, Jose M Pego-Reigosa, Isabel Castrejon, Jesús T Sanchez-Costa, Enrique González-Dávila, Federico Diaz-Gonzalez
47 [GO] 2021―Dec―08 Effects of the COVID-19 pandemic on patients with inflammatory joint diseases in Sweden: from infection severity to impact on care provision Hannah Bower, Thomas Frisell, Daniela di Giuseppe, Bénédicte Delcoigne, Gerd-Marfie Ahlenius, Eva Baecklund, Katerina Chatzidionysiou, Nils Feltelius, Helena Forsblad-d'Elia, Alf Kastbom, Lars Klareskog, Elisabet Lindqvist, Ulf Lindström, Carl Turesson, Christopher Sjowall, Johan Askling
48 [GO] 2021―Dec―08 Humoral protection to SARS-CoV2 declines faster in patients on TNF alpha blocking therapies Ulf M Geisen, Melike Sümbül, Florian Tran, Dennis K Berner, Hayley M Reid, Lena Vullriede, Maria Ciripoi, Ann C Longardt, Paula Hoff, Peter J Morrison, Verena E Schneider, Rainald Zeuner, Jan H Schirmer, Andrea Steinbach, Susanna Nikolaus, S Gerdes, Stefan Schreiber, Petra Bacher, Bimba F Hoyer
49 [GO] 2021―Dec―03 Incidence of COVID-19 in patients treated with infliximab compared with patients treated with rituximab Cathy Mireille Melong Pianta Taleng, Kim Lauper, Benoit Gilbert, Tim Cunningham, Romain Guemara, Laure Brulhart, Diana Dan, Delphine Courvoisier, Axel Finckh
50 [GO] 2021―Dec―03 Immunogenicity, safety and reactogenicity of a heterogeneous booster following the CoronaVac inactivated SARS-CoV-2 vaccine in patients with SLE: a case series Theerada Assawasaksakul, Seelwan Sathitratanacheewin, Preeyaporn Vichaiwattana, Nasamon Wanlapakorn, Yong Poovorawan, Wonngarm Kittanamongkolchai
51 [GO] 2021―Nov―24 Three-month and six-month outcomes of patients with COVID-19 associated hyperinflammation treated with short-term immunosuppressive therapy: follow-up of the CHIC study Marlou THF Janssen, Sofia Ramiro, Rémy LM Mostard, Cesar Magro-Checa, Robert BM Landewé
52 [GO] 2021―Nov―23 Efficacy and safety of colchicine in COVID-19: a meta-analysis of randomised controlled trials Kedar Gautambhai Mehta, Tejas Patel, Paragkumar D Chavda, Parvati Patel
53 [GO] 2021―Nov―01 Immunomodulatory therapies for the treatment of SARS-CoV-2 infection: an update of the systematic literature review to inform EULAR points to consider Alessia Alunno, Aurélie Najm, Xavier Mariette, Gabriele De Marco, Jenny Emmel, Laura Mason, Dennis G McGonagle, Pedro M Machado
54 [GO] 2021―Sep―07 Early experience of COVID-19 vaccination in adults with systemic rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey Sebastian Eduardo Sattui, Jean W Liew, Kevin Kennedy, Emily Sirotich, Michael Putman, Tarin T Moni, Akpabio Akpabio, Deshiré Alpízar-Rodríguez, Francis Berenbaum, Inita Bulina, Richard Conway, Aman Dev Singh, Eimear Duff, Karen L Durrant, Tamer A Gheita, Catherine L Hill, Richard A Howard, Bimba F Hoyer, Evelyn Hsieh, Lina El Kibbi, Adam Kilian, Alfred Hyoungju Kim, David F L Liew, Chieh Lo, Bruce Miller, Serena Mingolla, Michal Nudel, Candace A Palmerlee, Jasvinder A Singh, Namrata Singh, Manuel Francisco Ugarte-Gil, John Wallace, Kristen J Young, Suleman Bhana, Wendy Costello, Rebecca Grainger, Pedro M Machado, Philip C Robinson, Paul Sufka, Zachary S Wallace, Jinoos Yazdany, Carly Harrison, Maggie Larché, Mitchell Levine, Gary Foster, Lehana Thabane, Lisa G Rider, Jonathan S Hausmann, Julia F Simard, Jeffrey A Sparks
55 [GO] 2021―Jul―26 Clinical manifestations and outcome of SARS-CoV-2 infections in children and adolescents with rheumatic musculoskeletal diseases: data from the National Paediatric Rheumatology Database in Germany Claudia Sengler, Sascha Eulert, Kirsten Minden, Martina Niewerth, Gerd Horneff, Jasmin Kuemmerle-Deschner, Caroline Siemer, Rainer Berendes, Hermann Girschick, Regina Hühn, Michael Borte, Anton Hospach, Wolfgang Emminger, Jakob Armann, Ariane Klein, Tilmann Kallinich
56 [GO] 2021―May―06 Antiphospholipid antibodies in COVID-19: a meta-analysis and systematic review Muhanad Taha, Lobelia Samavati
57 [GO] 2021―May―03 Anxiety and concerns related to the work situation during the second wave of the COVID-19 pandemic in >5000 patients with inflammatory rheumatic disease followed in the DANBIO registry Bente Glintborg, Dorte Vendelbo Jensen, Sara Engel, Lene Terslev, Mogens Pfeiffer Jensen, Oliver Hendricks, Mikkel Østergaard, Simon Horskjær Rasmussen, Thomas Adelsten, Ada Colic, Kamilla Danebod, Malene Kildemand, Anne Gitte Loft, Heidi Lausten Munk, Jens Kristian Pedersen, René Drage Østgård, Christian Møller Sørensen, Niels Steen Krogh, Jette Nørgaard Agerbo, Connie Ziegler, Merete Lund Hetland
58 [GO] 2021―Apr―07 Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1) Marco Garrido-Cumbrera, Helena Marzo-Ortega, Laura Christen, Pedro Plazuelo-Ramos, Dale Webb, Clare Jacklin, Shantel Irwin, Laurent Grange, Souzi Makri, Elsa Frazão Mateus, Serena Mingolla, Katy Antonopoulou, Sergio Sanz-Gómez, José Correa-Fernández, Loreto Carmona, Victoria Navarro-Compán
59 [GO] 2021―Mar―31 COVID-19-induced hyperinflammation, immunosuppression, recovery and survival: how causal inference may help draw robust conclusions Robert B M Landewé, Sofia Ramiro, Rémy L M Mostard
60 [GO] 2021―Feb―24 Point of view on the vaccination against COVID-19 in patients with autoimmune inflammatory rheumatic diseases Victoria Furer, Christien Rondaan, Nancy Agmon-Levin, Sander van Assen, Marc Bijl, Meliha Crnkic Kapetanovic, Annette de Thurah, Ulf Mueller-Ladner, Daphna Paran, Karen Schreiber, Klaus Warnatz, Nico M Wulffraat, Ori Elkayam
61 [GO] 2021―Feb―24 Vaccination of patients with inflammatory rheumatic diseases against SARS-CoV-2: considerations before widespread availability of the vaccines Hendrik Schulze-Koops, Christof Specker, Alla Skapenko
62 [GO] 2021―Feb―23 Digital rheumatology in the era of COVID-19: results of a national patient and physician survey Anna Kernder, Harriet Morf, Philipp Klemm, Diana Vossen, Isabell Haase, Johanna Mucke, Marco Meyer, Arnd Kleyer, Philipp Sewerin, Gerlinde Bendzuck, Sabine Eis, Johannes Knitza, Martin Krusche
63 [GO] 2021―Feb―11 Pathophysiology of acute respiratory syndrome coronavirus 2 infection: a systematic literature review to inform EULAR points to consider Aurélie Najm, Alessia Alunno, Xavier Mariette, Benjamin Terrier, Gabriele De Marco, Jenny Emmel, Laura Mason, Dennis G McGonagle, Pedro M Machado
64 [GO] 2021―Feb―09 Correction: High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV brasil registry
65 [GO] 2021―Feb―06 Beneficial effects of colchicine for moderate to severe COVID-19: a randomised, double-blinded, placebo-controlled clinical trial Maria Isabel Lopes, Leticia P Bonjorno, Marcela C Giannini, Natalia B Amaral, Pamella Indira Menezes, Saulo Musse Dib, Samara Libich Gigante, Maira N Benatti, Uebe C Rezek, Laerte L Emrich-Filho, Betania A A Sousa, Sergio C L Almeida, Rodrigo Luppino Assad, Flavio P Veras, Ayda Schneider, Tamara S Rodrigues, Luiz O S Leiria, Larissa D Cunha, Jose C Alves-Filho, Thiago M Cunha, Eurico Arruda, Carlos H Miranda, Antonio Pazin-Filho, Maria Auxiliadora-Martins, Marcos C Borges, Benedito A L Fonseca, Valdes R Bollela, Cristina M Del-Ben, Fernando Q Cunha, Dario S Zamboni, Rodrigo C Santana, Fernando C Vilar, Paulo Louzada-Junior, Rene D R Oliveira
66 [GO] 2021―Jan―28 High levels of immunosuppression are related to unfavourable outcomes in hospitalised patients with rheumatic diseases and COVID-19: first results of ReumaCoV Brasil registry Claudia Diniz Lopes Marques, Adriana Maria Kakehasi, Marcelo Medeiros Pinheiro, Licia Maria Henrique Mota, Cleandro Pires Albuquerque, Carolina Rocha Silva, Gabriela Porfirio Jardim Santos, Edgard Torres Reis-Neto, Pedro Matos, Guilherme Devide, Andrea Dantas, Rina Dalva Giorgi, Adriana de Oliveira Marinho, Lilian David Azevedo Valadares, Ana Karla G Melo, Francinne Machado Ribeiro, Gilda Aparecida Ferreira, Flavia Patricia de Sena Santos, Sandra Lucia Euzebio Ribeiro, Nicole Pamplona Bueno Andrade, Michel Alexandre Yazbek, Viviane Angelina de Souza, Eduardo S Paiva, Valderilio Feijo Azevedo, Ana Beatriz Santos Bacchiega de Freitas, José Roberto Provenza, Ricardo Acayaba de Toledo, Sheilla Fontenelle, Sueli Carneiro, Ricardo Xavier, Gecilmara Cristina Salviato Pileggi, Ana Paula Monteiro Gomides Reis
67 [GO] 2021―Jan―21 Older age, comorbidity, glucocorticoid use and disease activity are risk factors for COVID-19 hospitalisation in patients with inflammatory rheumatic and musculoskeletal diseases Rebecca Hasseli, Ulf Mueller-Ladner, Bimba F Hoyer, Andreas Krause, Hanns-Martin Lorenz, Alexander Pfeil, Jutta Richter, Martin Schäfer, Tim Schmeiser, Anja Strangfeld, Hendrik Schulze-Koops, Reinhard E Voll, Christof Specker, Anne Constanze Regierer
68 [GO] 2021―Jan―17 Biological agents for rheumatic diseases in the outbreak of COVID-19: friend or foe? Cristiana Sieiro Santos, Xenia Cásas Férnandez, Clara Moriano Morales, Elvira Díez Álvarez, Carolina Álvarez Castro, Alejandra López Robles, Trinidad Pérez Sandoval
69 [GO] 2021―Jan―05 Self-protection strategies and health behaviour in patients with inflammatory rheumatic diseases during the COVID-19 pandemic: results and predictors in more than 12 000 patients with inflammatory rheumatic diseases followed in the Danish DANBIO registry Bente Glintborg, Dorte Vendelbo Jensen, Sara Engel, Lene Terslev, Mogens Pfeiffer Jensen, Oliver Hendricks, Mikkel Ostergaard, Simon Horskjær Rasmussen, Thomas Adelsten, Ada Colic, Kamilla Danebod, Malene Kildemand, Anne Gitte Loft, Heidi Lausten Munk, Jens Kristian Pedersen, René Drage Østgård, Christian Møller Sørensen, Niels Steen Krogh, Jette Agerbo, Connie Ziegler, Merete Hetland
70 [GO] 2020―Dec―28 Evidences for a protective role of vitamin D in COVID-19 Maurizio Cutolo, Sabrina Paolino, Vanessa Smith
71 [GO] 2020―Oct―21 Controversies over hydroxychloroquine in the prevention of SARS-CoV-2 infection put rheumatologists on the frontline Serena Bugatti, Ludovico De Stefano, Francesca Bobbio-Pallavicini, Carlomaurizio Montecucco
72 [GO] 2020―Oct―03 Impact of COVID-19 on vulnerable patients with rheumatic disease: results of a worldwide survey Bella Mehta, Deanna Jannat-Khah, Mark Alan Fontana, Carine J Moezinia, Carol A Mancuso, Anne R Bass, Vinicius C Antao, Allan Gibofsky, Susan M Goodman, Said Ibrahim
73 [GO] 2020―Sep―02 National registry for patients with inflammatory rheumatic diseases (IRD) infected with SARS-CoV-2 in Germany (ReCoVery): a valuable mean to gain rapid and reliable knowledge of the clinical course of SARS-CoV-2 infections in patients with IRD Rebecca Hasseli, Ulf Mueller-Ladner, Tim Schmeiser, Bimba F Hoyer, Andreas Krause, Hanns-Martin Lorenz, Anne Constanze Regierer, Jutta G Richter, Anja Strangfeld, Reinhard E Voll, Alexander Pfeil, Hendrik Schulze-Koops, Christof Specker
74 [GO] 2020―Aug―06 Reactive arthritis after COVID-19 infection Keisuke Ono, Mitsumasa Kishimoto, Teppei Shimasaki, Hiroko Uchida, Daisuke Kurai, Gautam A Deshpande, Yoshinori Komagata, Shinya Kaname
75 [GO] 2020―Jul―01 Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic Isabelle Koné-Paut, Rolando Cimaz
76 [GO] 2020―Jun―25 Rheumatology practice amidst the COVID-19 pandemic: a pragmatic view Vasco C Romão, Inês Cordeiro, Carla Macieira, Filipa Oliveira-Ramos, José Carlos Romeu, Carlos Miranda Rosa, Maria João Saavedra, Fernando Saraiva, Elsa Vieira-Sousa, João Eurico Fonseca
77 [GO] 2020―May―18 Storm, typhoon, cyclone or hurricane in patients with COVID-19? Beware of the same storm that has a different origin Alessia Alunno, Francesco Carubbi, Javier Rodríguez-Carrio
 [1] 

77 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec